Aviva’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-32,349
Closed -$3.74M 1041
2023
Q3
$3.74M Buy
32,349
+8,646
+36% +$929K 0.02% 544
2023
Q2
$2.44M Sell
23,703
-141,111
-86% -$14.9M 0.01% 598
2023
Q1
$18M Sell
164,814
-178,612
-52% -$19.7M 0.08% 360
2022
Q4
$39.1M Buy
343,426
+24,062
+8% +$2M 0.19% 117
2022
Q3
$19.8M Buy
319,364
+57,497
+22% +$4.02M 0.11% 243
2022
Q2
$20.9M Buy
261,867
+105,274
+67% +$9.97M 0.11% 242
2022
Q1
$16.5M Buy
156,593
+79,185
+102% +$7.72M 0.08% 297
2021
Q4
$8.34M Buy
77,408
+9
+0% +$982 0.04% 448
2021
Q3
$8.48M Buy
77,399
+7,139
+10% +$741K 0.04% 441
2021
Q2
$6.58M Buy
70,260
+5,557
+9% +$511K 0.03% 509
2021
Q1
$5.96M Buy
+64,703
New +$5.46M 0.03% 482

Other funds holding HZNP